Steve Laflin
Patrimonio netto: 728 842 $ in data 30/09/2026
Patrimonio netto: 728 842 $ in data 30/09/2026
Steve T.
Laflin is Chief Executive Officer at RadQual LLC since 2021.
Mr. Laflin is Director at Radnostix, Inc. since 2023.
Mr. Laflin was President & Chief Executive Officer at International Isotopes Idaho, Inc. from 1996 to 2001.
Mr. Laflin completed undergraduate studies at Idaho State University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
RADNOSTIX, INC. 2,42% | 26/05/2026 | 12.786.700 ( 2,42% ) | 728 842 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| RADNOSTIX, INC. | Direttore/Membro del Consiglio | 01/06/2001 |
RadQual LLC
RadQual LLC Medical SpecialtiesHealth Technology Manufactures quality control products for the nuclear medicine and PET imaging communities | Amministratore Delegato | 01/07/2021 |
| Società | Posizione | Fine |
|---|---|---|
International Isotopes Idaho, Inc.
International Isotopes Idaho, Inc. Pharmaceuticals: MajorHealth Technology Produces and supplies radioisotopes and brachytherapy for the treatment of cancer | Amministratore Delegato | 01/01/2001 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Radnostix, Inc.
Radnostix, Inc. Medical SpecialtiesHealth Technology Manufactures finished radiopharmaceuticals, pharmaceutical grade radiochemical, radioisotopes, brachytherapy medical devices | Health Technology |
Idaho State University
Idaho State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RadQual LLC
RadQual LLC Medical SpecialtiesHealth Technology Manufactures quality control products for the nuclear medicine and PET imaging communities | Health Technology |
International Isotopes Idaho, Inc.
International Isotopes Idaho, Inc. Pharmaceuticals: MajorHealth Technology Produces and supplies radioisotopes and brachytherapy for the treatment of cancer | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale